Teva Pharmaceutical Strengthens Board with New Appointment
Company Announcements

Teva Pharmaceutical Strengthens Board with New Appointment

Teva Pharmaceutical ( (TEVA) ) has provided an update.

Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust background in financial leadership and strategic roles at Syngenta Group and Goldman Sachs, Lichtenstein brings a wealth of expertise to Teva. His appointment reflects Teva’s strategic focus on enhancing its leadership with seasoned professionals in the financial and agricultural sectors.

Find detailed analytics on TEVA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTeva selloff brings good entry point, says UBS
TheFlyTeva put volume heavy and directionally bearish
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App